Bayer said on Wednesday it struck a global licence agreement for an experimental oral cancer drug for targeted therapies with China's Puhe BioPharma. March 24, 2025 Elliott urges Germany's RWE to ...
Some results have been hidden because they may be inaccessible to you
Feedback